Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Epidermal growth factor receptor –mutated non–small cell lung cancer: a clinical approach
CLINICAL PEARLS All patients with advanced, nonsquamous, non−small cell lung cancer (NSCLC) should undergo epidermal growth factor receptor (EGFR) mutation testing as a part of a broader molecular panel (e.g., targeted next-generation sequencing panel). EGFR tyrosine kinase inhibitors (TKIs) are…